Your Health Plan:
Your Health Plan:
Not SelectedFASENRA (benralizumab) is a biologic prescription drug for treatment of Asthma. FASENRA is a interleukin-5 receptor alpha-directed cytolytic antibody. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $5400-7500.
Patient Assistance Prorgams and Coupons are found:
No other option is found for FASENRA